MEGAN MARTIN: Open Payments
NPI 1790072114 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$469 in 25 payments from 7 companies in 2025. Trend: 2023 $355 · 2024 $279 · 2025 $469
Food & beverage: $469
| Company | Payments | Amount |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 15 | $150 |
| Vericel Corporation | 1 | $90 |
| Pacira Pharmaceuticals Incorporated | 3 | $89 |
| Goode Surgical Inc | 2 | $57 |
| Boston Scientific Corporation | 2 | $41 |
| Linvatec Corporation | 1 | $25 |
| Aroa Biosurgery Incorporated | 1 | $17 |
Products named: EUFLEXXA, MACI, Exparel, General - Pain Management, Iovera, BIOBRACE 23MM.
Industry payments across NV — which companies pay providers there.
